Published in
American Society of Hematology, Blood, 11(130), p. 1315-1326, 2017
DOI: 10.1182/blood-2017-02-766691
Links
Tools
FDG-PET–driven consolidation strategy in diffuse large B-cell lymphoma: final results of a randomized phase 2 study
Journal article published in 2017 by
R.-O. Casasnovas 
,
L. Ysebaert,
C. Thieblemont,
E. Bachy ,
P. Feugier,
A. Delmer ,
S. Tricot,
J. Gabarre,
M. Andre,
C. Fruchart,
N. Mounier,
R. Delarue,
M. Meignan,
A. Berriolo-Riedinger,
S. Bardet
and other authors.
,
L. Ysebaert,
C. Thieblemont,
E. Bachy ,
P. Feugier,
A. Delmer ,
S. Tricot,
J. Gabarre,
M. Andre,
C. Fruchart,
N. Mounier,
R. Delarue,
M. Meignan,
A. Berriolo-Riedinger,
S. Bardet
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 
Abstract
Key Points Superiority of R-ACVBP over R-CHOP14 was not established, as IHP criteria driving consolidation did not properly reflect disease control. The 26% PET2−/PET4− patients using IHP criteria increased to 79% using ΔSUVmax, which may help better select those needing an alternative to SIC.